(Q40659633)

22 September 2017

title

Hypermethylation of the P15INK4b and P16INK4a in agnogenic myeloid metaplasia (AMM) and AMM in leukaemic transformation (English)

1 reference

22 September 2017

1 reference

1 reference

1 reference

Jen C Wang

1

1 reference

22 September 2017

Wilson Chen

2

1 reference

22 September 2017

Selvarany Nallusamy

3

1 reference

22 September 2017

Chi Chen

4

1 reference

22 September 2017

Allan D Novetsky

5

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

British Journal of Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

116

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

582-586

1 reference

Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

Germline p16 mutations in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

Methylation of the p16INK4A gene in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

Low-dose 5-aza-2'-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03319.X

10.1046/J.0007-1048.2001.03319.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference